NFE2L2 and hepatocellular carcinoma: In this study, we demonstrate that PIP5K1A disrupts the KEAP1‐NRF2 interaction, stabilizing NRF2 and thereby suppressing ferroptosis and promoting sorafenib resistance in HCC cells.